DOC News Track the topics, authors and articles important to you
HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
 QUICK SEARCH:   [advanced]


     


DOC News    August 1, 2005
Volume 2 Number 8 p. 14
© 2005 American Diabetes Association

Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Preventing Metabolic Syndrome by Preventing Diabetes

Interventions designed to prevent the onset of type 2 diabetes reduce the risk of metabolic syndrome—a cluster of symptoms including hypertension, high serum lipids, glucose intolerance, and a large waist size—according to recently reported findings.

Investigators with the Diabetes Prevention Program Research Group conducted a study of more than 3,000 people with impaired glucose tolerance. Participants were randomized to receive treatment with an intensive lifestyle intervention, therapy with 850 mg of metformin twice daily, or placebo.

The lifestyle intervention was designed to achieve and maintain 7% weight loss through a low-calorie, low-fat diet and 150 minutes of exercise per week.

At the beginning of the study, 1,711 participants had metabolic syndrome. The severity of metabolic syndrome did not differ in terms of treatment group, age, or sex. Participants were followed for an average of 3.2 years.

The incidence of metabolic syndrome was reduced 41% among those who received the lifestyle intervention and 17% among those who took metformin, compared with those who received placebo.

The investigators note that strategies to address diabetes also reduce the development of metabolic syndrome, and that intensive lifestyle intervention appears more effective than metformin therapy.

Orchard TJ, Temprosa M, Goldberg R, et al.: The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial. Ann Intern Med 142:611–619, 2005.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
DOC News Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum